Clinical Trials · NCT02032784
Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- AdventHealth
- Enrollment
- 33
- Start date
- Mar 2014
- Locations
- 1 site, United States
- Primary endpoint
- Post endoscopic mucosal resection bleeding